Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.46%
#2 Ontology Gas Ontology Gas +131.75%
#3 PulseChain PulseChain +61.85%
#4 Osmosis Osmosis +35.55%
#5 BOOK OF MEME BOOK OF MEME +31.03%
#6 Ontology Ontology +30.60%
#7 Neiro Neiro +30.07%
#8 Collect on Fanable Collect on Fanable +28.80%
#9 Unit Pump Unit Pump +28.63%
#10 Pump.fun Pump.fun +28.63%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Mendus AB (publ) Mendus AB (publ)

Mendus AB (publ)

IMMU
Rank in Stocks #25836
Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB... Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB (publ) until its name change in June 2022, specializes in developing immunotherapies and vaccines designed to prevent cancer recurrence. Its primary investigational compound, ilixadencel, is currently progressing through a Phase II MERECA clinical study for kidney cancer, alongside Phase I/II trials targeting liver cancer and gastrointestinal stromal tumors. Additionally, the company is advancing DCP-001, which is undergoing Phase II ADVANCE-II clinical research for acute myeloid leukemia and Phase I/II ALISON trials for ovarian cancers. Mendus maintains research partnerships with PCI Biotech Holding ASA to explore novel cancer vaccination approaches and with the Icahn School of Medicine at Mount Sinai. Founded in 2002, Mendus AB is headquartered in Stockholm, Sweden.
Share Price
$0.74834668
Market Cap
$45.86M
Change (1 day)
-0.15%
Change (1 year)
-6.28%
Country
SE
Trade Mendus AB (publ) (IMMU)

Category

Healthcare
Stock price history for Mendus AB (publ) (IMMU)
Highest end of day price: $0.75 on 2026-08-01

Lowest end of day price: $1.01 on 2013-04-01
Stock price history of Mendus AB (publ) from 2013 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 14.43%
2025 -29.72%
2024 -32.55%
2023 -76.95%
2022 -39.21%
2021 -55.05%
2020 -17.38%
2019 29.23%
2018 -11.66%
2017 -59.00%
2016 -42.62%
2015 63.38%
2014 -42.62%
2013 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 36.71%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.86%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 7.04%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 385.07%
US